Our study further examined the effect of LT-NNK exposure and demonstrated upregulation of two of the most significant chemoresistance genes, MDR1 and ABCG2, and increased Oxaliplatin-induced chemoresistance (Figure 1B and 1C), suggesting LT-NNK exposure also facilitates tumor progression. This evidence concerns the gene ABCG2 and neoplasm.